South America Hemodialysis and Peritoneal Dialysis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Product, and End User

The hemodialysis and peritoneal dialysis market in South America is expected to grow from US$ 8,059.69 million in 2022 to US$ 11,772.43 million by 2028; it is estimated to grow at a CAGR of 6.5% from 2022 to 2028.

The increasing prevalence of chronic kidney disease (CKD) that demands promising diagnostic test options is among the factors contributing to the growth of the hemodialysis and peritoneal dialysis market in this region. The annual incidence of ESKD is 160 patients per million population, with hypertension and diabetes the most common causes/etiologies. For instance, ~29,929 patients with ESKD were on chronic dialysis, representing a prevalence rate of 673 patients per million population by the end of 2018; ~93.5% were on in-center/hospital hemodialysis and 6.5% on peritoneal dialysis. According to the American Society of Nephrology report, Argentina comprises dialysis units in hospitals and private settings. For instance, there are a total number of 597 dialysis centers in the country; 68% of these centers are government-owned, 63% are independent dialysis centers, and 26% are owned by foreign dialysis companies. Moreover, dialysis centers are covered by the patient's union health system or health insurance; however, the government is payable to such dialysis centers if the patient does not carry union or health insurance. The South & Central America hemodialysis and peritoneal dialysis market is segmented into Argentina, Brazil, and the Rest of South & Central America. The Rest of South & Central America comprises Chile, Colombia, Peru, and Ecuador. According to the National Institute of Health report, adults in need of RRT receive kidney transplantation, hemodialysis, or peritoneal dialysis in Chile. For instance, 95% of Chilean patients in need of RRT are currently treated with hemodialysis and 4.5% with peritoneal dialysis, with only a few patients receiving a transplant. In 2008, Ecuador's government recognized CKD as a catastrophic illness and, from 2012, committed to guaranteeing medical attention to CKD patients, including dialysis procedures in ESKD cases. Such factors positively influence conducting hemodialysis and peritoneal dialysis procedures in Ecuador, thus driving the market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South America hemodialysis and peritoneal dialysis market. The South America hemodialysis and peritoneal dialysis market is expected to grow at a good CAGR during the forecast period.

South America Hemodialysis and Peritoneal Dialysis Market Segmentation

The South America hemodialysis and peritoneal dialysis market is segmented into type, product, end user, and country.

• Based on type, the market is bifurcated into hemodialysis and peritoneal dialysis. In 2022, the hemodialysis segment is expected to hold a larger market share.
• Based on product, the hemodialysis and peritoneal dialysis market is segmented into devices, consumables, and services. The services segment is likely to hold the largest market share in 2022.
• Based on end user, the market is segmented into hospital-based and home-based. The hospital-based segment is expected to account for a larger share in 2022.
• Based on country, the South America hemodialysis and peritoneal dialysis market is segmented into Brazil, Argentina, and the Rest of South America. The Rest of South America is expected to hold the largest market share in 2022.

Asahi Kasei Medical Co., Ltd.; B. Braun Melsungen AG; Baxter International Inc.; DaVita Inc.; Dialife SA; Diaverum; Fresenius Medical Care AG & Co KGaA; and Rockwell Medical, Inc. are among the leading companies in the South America hemodialysis and peritoneal dialysis market.